Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

Published:2015-11-24 Issue:40 Volume:6 Page:42396-42410
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Di Desidero Teresa¹²,Xu Ping¹,Man Shan¹,Bocci Guido²,Kerbel Robert S.¹³

Affiliation:

1. Biologic Sciences Platform, Sunnybrook Research Institute, Toronto, Canada

2. Divisione di Farmacologia, Dipartimento di Medicina Clinica e Sperimentale, University of Pisa, Pisa, Italy

3. Department of Medical Biophysics, University of Toronto, Toronto, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vessel co-option: a unique vascular-immune niche in liver cancer;Frontiers in Oncology;2024-04-26

2. Metronomic Chemotherapy in Elderly Patients;Current Oncology Reports;2024-03-07

3. Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology;Heliyon;2024-02

4. Cost-effectiveness of Metronomic chemotherapy vs Weekly Intravenous Paclitaxel in patients with ER+/HER2-Metastatic Breast Cancer;2024-01-23

5. Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib;Biochemical Pharmacology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP